上海疫苗研发取得新进展:小鼠免疫实验已产生特异性抗体 - 2020年03月17日

A candidate vaccine for the novel coronavirus is expected to enter clinical trials next month, city official Zhang Quan told a press conference on Monday.
At present, researchers are carrying out toxicity tests of the mRNA vaccine on primates to gauge its safety and effectiveness. Clinical trials are expected to start in the middle of April, according to Zhang, director of the Shanghai Science and Technology Commission.
City researchers have also made progress on the development of another candidate, VLP vaccine. In lab testing, mice produced a special antibody, he said.